Adrenal nodularity and somatic mutations in primary aldosteronism: One node is the culprit?

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 7, 2014, Pages

  Dekkers, T ^a   Ter Meer, M ^a   Lenders, J W M ^a   Hermus, A R M ^a   Schultze Kool, L ^a   Langenhuijsen, J F ^a   Nishimoto, K ^b   Ogishima, T ^c   Mukai, K ^b   Azizan, E A B ^d   Tops, B ^a   Deinum, J ^a   Kusters B ^a,e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KEIO UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CYTOCHROME P450; CYTOCHROME P450 C11; CYTOCHROME P450 C18; HYDROCORTISONE; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; AGED; ARTICLE; ATP1A1 GENE; ATP2B3 GENE; CACNA1D GENE; FEMALE; GENE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KCNJ5 GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NODULAR HYPERPLASIA; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SOMATIC MUTATION; ZONA FASCICULATA; ZONA GLOMERULOSA;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; ADULT; AGED; ALDOSTERONE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERPLASIA; MALE; MIDDLE AGED; MUTATION; TUMOR BURDEN; YOUNG ADULT;

EID: 84904052297     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4255     Document Type: Article

References (37)

1. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
2. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045-1050. (Pubitemid 38368386)
3. Satoh F, Abe T, Tanemoto M, et al. Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling. Hypertens Res. 2007;30:1083-1095.
4. Lo CY, Tam PC, Kung AW, Lam KS, Wong J. Primary aldosteronism. Results of surgical treatment. Ann Surg. 1996;224:125-130. (Pubitemid 26272057)
5. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res. 2007;30:111-117. (Pubitemid 46541784)
6. Enberg U, Volpe C, Hoog A, et al. Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2. Eur J Endocrinol. 2004;151:73-85. (Pubitemid 39117367)
7. Scholl UI, Nelson-Williams C, Yue P, et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci USA. 2012;109:2533-2538.
8. Akerstrom T, Crona J, Delgado Verdugo A, et al. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PloS One. 2012;7:e41926.
9. Murashima M, Trerotola SO, Fraker DL, Han D, Townsend RR, Cohen DL. Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience. J Clin Hypertens (Greenwich). 2009;11:316-323.
10. Proye CA, Mulliez EA, Carnaille BM, et al. Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery. 1998;124:1128-1133. (Pubitemid 28555205)
11. Tresallet C, Salepcioglu H, Godiris-Petit G, Hoang C, Girerd X, Menegaux F. Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology. Surgery. 2010;148:129-134.
12. Weisbrod AB, Webb RC, Mathur A, et al. Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism. Ann Surg Oncol. 2013;20:753-758.
13. Nanba K, Tsuiki M, Sawai K, et al. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J Clin Endocrinol Metab. 2013;98:1567-1574.
14. Iacobone M, Citton M, Viel G, et al. Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. Surgery. 2012;152:1248-1255.
15. Sigurjonsdottir HA, Gronowitz M, Andersson O, et al. Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocrine Disorders. 2012;12:17.
16. Quillo AR, Grant CS, Thompson GB, Farley DR, Richards ML, Young WF. Primary aldosteronism: results of adrenalectomy for nonsingle adenoma. J Am Coll Surg. 2011;213:106-112; discussion 112-113.
17. Ganguly A. Cellular origin of aldosteronomas. Clin invest. 1992;70:392-395.
18. Nishimoto K, Nakagawa K, Li D, et al. Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab. 2010;95:2296-2305.
19. Shigematsu K, Yamaguchi N, Nakagaki T, Sakai H. A case of unilateral adrenal hyperplasia being difficult to distinguish from aldosterone-producing adenoma. Exp Clin Endocrinol Diabetes. 2009;117:124-128.
20. Fallo F, Pezzi V, Barzon L, et al. Quantitative assessment of CYP11B1 and CYP11B2 expression in aldosterone-producing adenomas. Eur J Endocrinol. 2002;147:795-802. (Pubitemid 36032969)
21. Boulkroun S, Samson-Couterie B, Dzib JF, et al. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. Hypertension. 2010;56:885-892.
22. Choi M, Scholl UI, Bjorklund P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772.
23. Beuschlein F, Boulkroun S, Osswald A, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45:440-444.
24. Azizan EA, Poulsen H, Tuluc P, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet. 2013;45:1055-1060.
25. Azizan EA, Murthy M, Stowasser M, et al. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension. 2012;59:587-591.
26. Azizan EA, Lam BY, Newhouse SJ, et al. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. J Clin Endocrinol Metab. 2012;97(5):E819-E829.
27. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. American Heart Association. Circulation. 2002;106:1572-1585.
28. Monticone S, Hattangady NG, Nishimoto K, et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab. 2012;97:E1567-E1572.
29. Taguchi R, Yamada M, Nakajima Y, et al. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab. 2012;97:1311-1319.
30. Xekouki P, Hatch MM, Lin L, et al. KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome. Endocr Relat Cancer. 2012;19:255-260.
31. Rizek P, Gorecki P, Lindenmayer A, Moktan S. Laparoscopic adrenalectomy for bilateral metachronous aldosteronomas. JSLS J Soc Laparoendosc Surg. 2011;15:100-104.
32. Calvo-Romero JM, Ramos-Salado JL. Recurrence of adrenal aldosterone-producing adenoma. Postgrad Med J. 2000;76:160-161. (Pubitemid 30152676)
33. Schwartz GL, Chapman AB, Boerwinkle E, Kisabeth RM, Turner ST. Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clin Chem. 2002;48:1919-1923. (Pubitemid 35222749)
34. Jansen PM, Boomsma F, van den Meiracker AH, Dutch ARRAT Investigators. Aldosterone-to-renin ratio as a screening test for primary aldosteronism - the Dutch ARRAT Study. The Neth J Med. 2008;66:220-228. (Pubitemid 351772008)
35. Salva M, Cicala MV, Mantero F. Primary aldosteronism: the role of confirmatory tests. Horm Metab Res. 2012;44:177-180.
36. Kempers MJ, Lenders JW, van Outheusden L, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009;151:329-337.
37. Kline GA, Harvey A, Jones C, et al. Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used. Variable interpretation of adrenal vein sampling. Int Urol Nephrol. 2008;40:1035-1043.